GlycoGenetics, Inc. is a glycobiology-centric biotechnology company. We have dedicated our R&D in developing highly integrated technologies for deciphering the complex glycocodes of human biology. With the ultimate goal of addressing the current obstacles in applying glycobiology for unmet medical needs, we provide our customers glycan-detecting reagents and services to develop disease biomarkers and to develop new therapeutic targets.